S3350 (2023-24 session)

NY State bill

Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.

Title
Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry
Type
New York State Senate bill
Session
2023-24 session
Status
In Senate Committee
Latest action date
2024-01-03
In committee
Health
Introduced
2023-01-30
Law section
Public Health Law

Sponsors

Heard in committee

Sources